Last fall, Amgen also acquired Mountain View,.
Following Amgen’s $420 million acquisition of Ilypsa, that makes $720 million the big biotech has dropped on startups this week — a substantial sum by any measure. . Last fall, Amgen also acquired Mountain View, Calif.-based Avidia for up to $380 million, so that’s well over $1 billion it has committed to startup acquisitions over the past nine months.
Original text search at: venturebeat.com/index.php?tag=co%3aamgen